Abcam plc (ABCZF)

22.25 0.00 (0.00%) At close: 10:38AM EDT

Abcam plc

Discovery Drive
Cambridge Biomedical Campus
Cambridge CB2 0AX
United Kingdom
44 12 2369 6000
https://www.abcam.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 1,760

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Markus Lusser	President	N/A	N/A	N/A
Marc Leigh Russell Perkins	General Counsel & Company Secretary	N/A	N/A	N/A
Emma Sceats	Senior Vice President of Sales & Marketing	N/A	N/A	N/A
Ms. Alejandra Solache Ph.D.	Senior Vice President of Research & Development	N/A	N/A	N/A
Mr. John Baker	Senior Vice President of Supply Chain & Manufacturing	N/A	N/A	N/A
Juan Carlos Sacristan	Senior Vice President of Data & Digital	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. As of December 6, 2023, Abcam plc operates as a subsidiary of Danaher Corporation.

Corporate Governance

Abcam plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.